The Trump administration has cancelled $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses. In addition, since President Donald Trump took office, at least half ...

Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express ...

If enacted, the GOP’s spending bill could kick more than 10 million Americans off Medicaid. Experts are worried about the ...

UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory ...

Acquiring FarmboxRx will help Pyx Health tackle food insecurity, a challenge many of its members struggle with.

Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine ...

The bottom line is that while recognizing there is an issue is vital, too many healthcare organizations are counting on ...

Clinical research sites face an information challenge that hinders efficiency and collaboration. As trial complexity increases, the multiple logins, devices, and spreadsheets site staff use to ...

Over the years, Glen Tullman’s disdain for healthcare players like payers, care navigators and benefits consultants has been well documented. Tullman founded Transcarent in 2020 with the notion ...

Synapticure, a virtual care company for neurodegenerative diseases, has secured $25 million in Series A funding to scale its services and expand its partnerships with health systems, payers and ...

Fem Therapeutics won the Canadian Pitch Track at MedCity INVEST this week after it was favored by the audience over three other health tech and medtech startups. Fem Therapeutics is a Montreal ...